T45.1X5S - Adverse effect of antineopl and immunosup drugs, sequela

The ICD 10 Code for Adverse effect of antineopl and immunosup drugs, sequela is listed as T45.1X5S.
Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.

ICD 10 CM Field	Value
Diagnosis Code:	T45.1X5S
Description:	Adverse effect of antineopl and immunosup drugs, sequela
Diagnostic Related Groups (MS-DRG v30.0)	922 - Other Injury, Poisoning & Toxic Effect Diag W Mcc 923 - Other Injury, Poisoning & Toxic Effect Diag W/o Mcc

Chapter	Injury, poisoning and certain other consequences of external causes (S00-T88)
Block	Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
Parent	T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs
ICD-9-CM Diagnosis Codes General Equivalence Mappings (GEMS):
ICD 9 Dx Code:	Combination: 909.5 - Late effect of adverse effect of drug, medicinal or biological substance with E933.1 - Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use
ICD-10-CM Siblings (same level / similar specificity) of T45.1X5S:
T45.1X5A - Adverse effect of antineoplastic and immunosup drugs, init
T45.1X5D - Adverse effect of antineoplastic and immunosup drugs, subs